|
LNX2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28210000005513E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.44910000022503E-07 |
| Normal-vs-Stage2 |
8.583900E-03 |
| Normal-vs-Stage3 |
3.215900E-04 |
| Normal-vs-Stage4 |
2.36909999995483E-06 |
| Stage1-vs-Stage2 |
9.889800E-01 |
| Stage1-vs-Stage3 |
4.602200E-01 |
| Stage1-vs-Stage4 |
2.473400E-01 |
| Stage2-vs-Stage3 |
5.905000E-01 |
| Stage2-vs-Stage4 |
2.686800E-01 |
| Stage3-vs-Stage4 |
5.099000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.58670000000227E-06 |
| Normal-vs-AfricanAmerican |
1.7677100000002E-05 |
| Normal-vs-Asian |
4.02659999998445E-06 |
| Caucasian-vs-AfricanAmerican |
6.467400E-01 |
| Caucasian-vs-Asian |
2.699600E-02 |
| AfricanAmerican-vs-Asian |
1.254830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.67450000046976E-07 |
| Normal-vs-Female |
6.555400E-03 |
| Male-vs-Female |
5.153800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.007200E-04 |
| Normal-vs-Extreme_Weight |
1.64869999985662E-07 |
| Normal-vs-Obese |
7.397400E-04 |
| Normal-vs-Extreme_Obese |
5.524200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.809800E-01 |
| Normal_Weight-vs-Obese |
3.378600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.030800E-01 |
| Extreme_Weight-vs-Obese |
1.203370E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.339200E-01 |
| Obese-vs-Extreme_Obese |
7.477400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.1985999998364E-07 |
| Normal-vs-Age(41-60Yrs) |
2.173100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.99299999997993E-06 |
| Normal-vs-Age(81-100Yrs) |
6.20369999999593E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.955400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.144100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.669400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.171000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.248800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.295400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.1443999999613E-06 |
| Normal-VS-Type2 PRCC |
1.77216999999175E-05 |
| Normal-VS-KIRP CIMP |
1.28880000005438E-08 |
| Normal-VS-Unclassified PRCC |
2.079400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.239600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.387000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.474400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.761900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.679650E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.838500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.35890000041839E-07 |
| Normal-vs-N1 |
1.01819999998032E-06 |
| Normal-vs-N2 |
1.92864999999376E-05 |
| N0-vs-N1 |
8.266600E-01 |
| N0-vs-N2 |
1.102360E-02 |
| N1-vs-N2 |
2.511400E-01 |
|
|
